Ŀ Akdeniz Üniversitesi 2007 Yılı SCI Yayınlar

Total Page:16

File Type:pdf, Size:1020Kb

Ŀ Akdeniz Üniversitesi 2007 Yılı SCI Yayınlar 2007 Akdeniz Üniversitesi 2007 Yılı SCI Yayınlar Akdeniz Üniversitesi Tıp Fakültesi Dekanlığı ŀ İçindekiler TEMEL TIP BİLİMLERİ Anatomi Anabilim Dalı Biyofizik Anabilim Dalı Fizyoloji Anabilim Dalı Histoloji ve Embriyoloji Anabilim Dalı Tıbbi Biyokimya Anabilim Dalı Tıbbi Biyoloji Anabilim Dalı Tıbbi Mikrobiyoloji Anabilim Dalı Tıp Eğitimi Anabilim Dalı DAHİLİ TIP BİLİMLERİ Acil Tıp Anabilim Dalı Aile Hekimliği Anabilim Dalı Çocuk Sağlığı ve Hastalıkları Anabilim Dalı Deri ve Zührevi Hastalıklar Anabilim Dalı Enfeksiyon Hastalıkları Anabilim Dalı Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı Göğüs Hastalıkları Anabilim Dalı Halk Sağlığı Anabilim Dalı İç Hastalıkları Anabilim Dalı Kardiyoloji Anabilim Dalı Nöroloji Anabilim Dalı Radyasyon Onkolojisi Anabilim Dalı Tıbbi Farmakoloji Anabilim Dalı CERRAHİ TIP BİLİMLERİ Beyin ve Sinir Cerrahisi Anabilim Dalı Göğüs Cerrahisi Anabilim Dalı Göz Hastalıkları Anabilim Dalı Kadın Hastalıkları ve Doğum Anabilim Dalı Kulak, Burun ve Boğaz Hastalıkları Anabilim Dalı Ortopedi ve Travmatoloji Anabilim Dalı Plastik ve Rekonstrüktif Estetik Cerrahi Anabilim Dalı Tıbbi Patoloji Anabilim Dalı Üroloji Anabilim Dalı Anatomi Anabilim Dalı - 2007 1-Sarikcioglu L, Arican RY:Wilhelm Heinrich Erb (1840-1921) and his contributions to neuroscience.J Neurol Neurosurg Psychiatry78:(7),732,2007. 2-Yildirim FB, Soyuncu Y, Oguz N, Aydin AT, Sindel M, Ustunel I:Anterior intermeniscal ligament: An ultrastructural study.Annals of Anatomy189:(5), 510-4, 2007. 3-Yildirim FB, Sarikcioglu L:Marie jean pierre flourens (1794-1867): an extraordinary scientist of his time.J Neurol Neurosurg Psychiatry78:(8),852,2007. 4-Sarikcioglu L:Otfrid foerster (1873-1941): one of the distinguished neuroscientists of his time.J Neurol Neurosurg Psychiatry78:(6),650,2007. 5-Sarikcioglu L, Demirel BM, Ozsoy U, Gurer EI, Oguz N, Ucar Y:Angiolipoma located inside the obturator canal and supplied by the umbilical artery.Annals of Anatomy189:(1),75-8,2007. 6-Sarikcioglu L:Johann bernhard aloys von gudden:an outstanding scientist.J Neurol Neurosurg Psychiatry78:(2),195,2007. 7-Sarikcioglu L, Demir N, Demirtop A:A standardized method to create optic nerve crush:Yasargil aneurysm clip.Exp Eye Res.84:(2),373-7,2007. 8-Sarikcioglu L, Duygulu E, Aydin H, Gurer EI,Ozkan O, Tuzuner S:Effects of intrathecal administration of FK506 after sciatic nerve crush J Reconstr Microsurg22:(8),649-54,2006. 9-Coskun N, Karaali K, Cevikol C:Anatomical basics and variations of the scapula in Turkish adultsSaudı Medical Journal 27:(9),1320-5,2006. 10-Sarikcioglu L, Yaba A, Tanriover G, Demirtop A, Demir N, Ozkan O:Effect of severe crush injury on axonal regeneration: a functional and ultrastructural study.J Reconstr Microsurg23:(3),143,2007. ŀ Amyloidogenic transthyretin variant, Gly53Ala 195 4 Blevins G, Macaulay R, Harder S, et al. Oculoleptomeningeal amyloidosis in a 9 Dickson PW, Schreiber G. High levels of messenger RNA for transthyretin large kindred with a new transthyretin variant Tyr69His. Neurology (prealbumin) in human choroid plexus. Neurosci Lett 1986;66:311–15. 2003;60:1625–30. 10 Stangou AJ, Hawkins PN. Liver transplantation in transthyretin-related familial 5 Herrick MK, DeBruyne K, Horoupian DS, et al. Massive leptomeningeal amyloidosis amyloid polyneuropathy. Curr Opin Neurol 2004;17:615–20. associated with a Val30Met transthyretin gene. Neurology 1996;47:988–92. 11 Adams D, Samuel D, Goulon-Goeau C, et al. The course and prognostic factors 6 Mitsuhashi S, Yazaki M, Tokuda T, et al. MRI analysis on a patient with the V30M of familial amyloid polyneuropathy after liver transplantation. Brain mutation is characteristic of leptomeningeal amyloid. Amyloid 2004;11:265–7. 2000;123:1495–504. 7 Munar-Ques M, Salva-Ladaria L, Mulet-Perera P, et al. Vitreous amyloidosis after 12 Ando Y, Terazaki H, Nakamura M, et al. A different amyloid formation liver transplantation in patients with familial amyloid polyneuropathy: ocular mechanism: de novo oculoleptomeningeal amyloid deposits after liver synthesis of mutant transthyretin. Amyloid 2000;7:266–9. transplantation. Transplantation 2004;77:345–9. 8 Schreiber G, Aldred AR, Jaworowski A, et al. Thyroxine transport from blood 13 Ellie E, Camou F, Vital A, et al. Recurrent subarachnoid hemorrhage to brain via transthyretin synthesis in choroid plexus. Am J Physiol associated with a new transthyretin variant (Gly53Glu). Neurology 1990;258(Pt 2):R338–45. 2001;57:135–7. HISTORICAL NOTE .............................................................................................. doi: 10.1136/jnnp.2006.106633 Johann Bernhard Aloys von Gudden: an outstanding scientist ohann Bernhard Aloys von Gudden was a visionary technique of secondary degeneration to study important inter- psychiatrist and neuroanatomist. He dedicated himself to relationships between the cortical and subcortical structures. Jneurobiology and was far more than a consulting psychia- Today, this method, based on retrograde neuronal cell body trist to the Bavarian royal family. Some well-known scientists changes observed after nervous system lesions, is still referred such as Emil Kraepelin (1856–1926), Franz Nissl (1860–1919), to as the von Gudden method. A published article1 shows that Auguste-Henri Forel (1848–1931) and Sigbert Josef Maria he was clearly aware of the limitations of this method; he was Ganser (1853–1931) studied under his supervision. not so much interested in the description of brain centres, but von Gudden was born in Kleve, in lower Rhineland near the was concerned with the independencies and connections Dutch frontier, on 7 June 1824. He was the third of seven sons of between the centres. Johannes Gudden, a landed proprietor, owner of a brewery and Macroscopic observation was widely used in von Gudden’s member of the town council. In 1843, he began his studies in time, as microscopy was still unsatisfactory. Therefore, he philosophy and medicine at the university in Bonn. For his pioneered the development of a microtome, the so-called doctoral dissertation, von Gudden studied torsional eye move- Gudden’s microtome,2 for sectioning the human brain, and ment under the supervision of Alfred Volkman (1800–77) at Halle. using this he described the important neuroanatomical centres. He received his medical degree in 1848 and in the same year His assistant, Auguste-Henri Forel, subsequently improved the passed with distinction the state medical examination in Berlin. microtome, and thus he was able to obtain entire human brain Thereafter, he obtained a position at the Siegburg asylum as an sections, at about 55 mm in thickness. assistant under the supervision of Karl Wigand Maximilian Jacobi von Gudden is perhaps best known for his studies on partial (1775–1858), one of the leading German psychiatrists. decussation of the optic paths, a subject that kept him occupied After completing his studies in Berlin in 1849, von Gudden for around 30 years. His method of producing secondary served in the army for a year. From 1851 to 1855, he worked with atrophy of central structures after the removal of sense organs Christian Friedrich Wilhelm Roller (1802–78) in the Illenau or cranial nerves in young animals ushered in a fresh advance asylum near Achern, the first modern psychiatric hospital in in experimental neurology. In fully grown animals, from which Germany. He married Roller’s granddaughter Clarissa Voigt in eyes had been removed when they were young, he showed not 1855, and, in the summer of the same year at the age of 31, was only crossed and uncrossed optic fibres but also a supraoptic appointed the director of Werneck, a newly established asylum commissure and the transverse peduncular tract. Both of these in northern Bavaria. In October 1869, von Gudden became tracts now bear his name. He was the first to describe the director of the newly founded Burgho¨lzli psychiatric hospital in Zu¨rich, Switzerland, and in 1870, was appointed co-editor of interpeduncular nucleus and the tegmental nuclei, known to all Archiv fu¨r Psychiatry und Nervenkrankheiten. In 1872, he took over who work in the midbrain today as the dorsal and ventral the direction of the Oberbayerische Kreis-Irrenanstalt in nuclei, respectively, of Gudden. Munich, and subsequently became a full professor of psychiatry One of Gudden’s greatest contributions was his observation at the University of Munich. in 1870 that destruction of certain areas of the cerebral cortex At the height of his career, von Gudden was commissioned to leads to atrophy of specific thalamic nuclei. Augustus Volney provide psychiatric care for the Bavarian royal family. He was Waller believed that, after a cut, the cell body and central stump the personal doctor of the mentally diseased Crown Prince of the nerve remained normal, but Gudden found that they Rudolf Otto (1848–1916) for many years. He took responsibility showed signs of atrophy. Accordingly, he launched a series of for the everyday care of the crown prince, who was secluded in investigations in which he used his ‘‘secondary degeneration Furstenried, a castle near Munich, and subsequently was technique’’—that is, the Gudden method—to trace connections assigned to examine and treat King Ludwig II of Bavaria between the main centres of the brain. (1845–86). On 13 July, 2 days after King Ludwig II was arrested Levent Sarikcioglu at Castle Neuschwanstein, Ludwig II and Bernhard von Gudden drowned in Starnberg Lake, close to the castle of Correspondence to: Dr L Sarikcioglu, Department of Anatomy, Akdeniz Berg. The details surrounding their death remain unclear. For University, Faculty of Medicine Campus, Antalya 07070, Turkey; some incomprehensible reason, no autopsy was ever performed [email protected] on von Gudden to determine the cause of death. In the last 14 years of his life, von Gudden devoted himself to References the study of neuroanatomy, a rapidly developing science in the 1 von Gudden JBA. Experimentaluntersuchungen bei das peripherischer und 19th century. He was the first neuroanatomist to create lesions centrale Nervensystem. Arch Psychiatr Nervenkr 1870;2:693–723. in the nervous system of newborn animals and to study the 2 von Gudden B.U¨ber ein neues microtom.
Recommended publications
  • New York Chapter American College of Physicians Annual
    New York Chapter American College of Physicians Annual Scientific Meeting Poster Presentations Saturday, October 12, 2019 Westchester Hilton Hotel 699 Westchester Avenue Rye Brook, NY New York Chapter American College of Physicians Annual Scientific Meeting Medical Student Clinical Vignette 1 Medical Student Clinical Vignette Adina Amin Medical Student Jessy Epstein, Miguel Lacayo, Emmanuel Morakinyo Touro College of Osteopathic Medicine A Series of Unfortunate Events - A Rare Presentation of Thoracic Outlet Syndrome Venous thoracic outlet syndrome, formerly known as Paget-Schroetter Syndrome, is a condition characterized by spontaneous deep vein thrombosis of the upper extremity. It is a very rare syndrome resulting from anatomical abnormalities of the thoracic outlet, causing thrombosis of the deep veins draining the upper extremity. This disease is also called “effort thrombosis― because of increased association with vigorous and repetitive upper extremity activities. Symptoms include severe upper extremity pain and swelling after strenuous activity. A 31-year-old female with a history of vascular thoracic outlet syndrome, two prior thrombectomies, and right first rib resection presented with symptoms of loss of blood sensation, dull pain in the area, and sharp pain when coughing/sneezing. When the patient had her first blood clot, physical exam was notable for swelling, venous distension, and skin discoloration. The patient had her first thrombectomy in her right upper extremity a couple weeks after the first clot was discovered. Thrombolysis with TPA was initiated, and percutaneous mechanical thrombectomy with angioplasty of the axillary and subclavian veins was performed. Almost immediately after the thrombectomy, the patient had a rethrombosis which was confirmed by ultrasound.
    [Show full text]
  • Role of Cornification and Triglyceride Synthesis Genes
    Gillespie et al. BMC Genomics 2013, 14:169 http://www.biomedcentral.com/1471-2164/14/169 RESEARCH ARTICLE Open Access Transcriptome analysis of pigeon milk production – role of cornification and triglyceride synthesis genes Meagan J Gillespie1,2*, Tamsyn M Crowley1,3, Volker R Haring1, Susanne L Wilson1, Jennifer A Harper1, Jean S Payne1, Diane Green1, Paul Monaghan1, John A Donald2, Kevin R Nicholas3 and Robert J Moore1 Abstract Background: The pigeon crop is specially adapted to produce milk that is fed to newly hatched young. The process of pigeon milk production begins when the germinal cell layer of the crop rapidly proliferates in response to prolactin, which results in a mass of epithelial cells that are sloughed from the crop and regurgitated to the young. We proposed that the evolution of pigeon milk built upon the ability of avian keratinocytes to accumulate intracellular neutral lipids during the cornification of the epidermis. However, this cornification process in the pigeon crop has not been characterised. Results: We identified the epidermal differentiation complex in the draft pigeon genome scaffold and found that, like the chicken, it contained beta-keratin genes. These beta-keratin genes can be classified, based on sequence similarity, into several clusters including feather, scale and claw keratins. The cornified cells of the pigeon crop express several cornification-associated genes including cornulin, S100-A9 and A16-like, transglutaminase 6-like and the pigeon ‘lactating’ crop-specific annexin cp35. Beta-keratins play an important role in ‘lactating’ crop, with several claw and scale keratins up-regulated. Additionally, transglutaminase 5 and differential splice variants of transglutaminase 4 are up-regulated along with S100-A10.
    [Show full text]
  • Top 100 Neurology Greats
    TOP 100 NEUROLOGY GREATS 1. Raymond ADAMS 2. William John ADIE 3. Theophile ALAJOUANINE 4. Thomas Clifford ALLBUTT 5. Alois ALZHEIMER 6. Julius ARNOLD 7. Joseph BABINSKI 8. Jean Alexander BARRE 9. Charles BELL 10. Hans BERGER 11. Claude BERNARD 12. Walter Russell BRAIN 13. Paul BROCA 14. Korbinian BRODMANN 15. Santiago Ramón y CAJAL 16. Walter Bradford CANNON 17. Jean-Martin CHARCOT 18. Hans CHIARI 19. Macdonald CRITCHLEY 20. Hans Gerherdt CRUETZFELDT 21. Walter Edward DANDY 22. Derek DENNY-BROWN 23. Joseph Jules DEJERINE 24. Francis Xavier DERCUM 25. Guillaume DUCHENNE The Neurology Lounge http://www.theneurologylounge.com/ TOP 100 NEUROLOGY GREATS 26. Ludwig EDINGER 27. Wilhelm Heinrich ERB 28. David FERRIER 29. Charles Miller FISHER 30. Edward FLATAU 31. Charles FOIX 32. Otfrid FOERSTER 33. Sigmund FREUD 34. Nikolaus FRIEDREICH 35. Raymond GARCIN 36. Henri GASTAUT 37. Norman GESCHWIND 38. Samuel GOLDFLAM 39. William Richard GOWERS 40. Georges GUILLAIN 41. Graeme HAMMOND 42. Anita HARDING 43. Henry HEAD 44. Johann HOFFMANN 45. Gordon Morgan HOLMES 46. Johann Friedrich HORNER 47. James Ramsay HUNT 48. George HUNTINGTON 49. Alfons Maria JAKOB 50. John Hughlings JACKSON The Neurology Lounge http://www.theneurologylounge.com/ TOP 100 NEUROLOGY GREATS 51. Herbert Henri JASPER 52. Smith Ely JELLIFFE 53. Robert Foster KENNEDY 54. Erik Klas Hendrik KUGELBERG 55. Sergei Sergeievich KORSAKOFF 56. Hugo Karl LIEPMANN 57. John Newport LANGLEY 58. William Gordon LENNOX 59. Arvid LINDAU 60. Gheorghe MARINESCU 61. Rita LEVI-MONTALCINI 62. Friedrich Heinrich LEWY 63. Jean LHERMITTE 64. Pierre MARIE 65. C David MARSDEN 66. Brian McARDLE 67. H Houston MERRITT 68.
    [Show full text]
  • Anti-Inflammatory Role of Curcumin in LPS Treated A549 Cells at Global Proteome Level and on Mycobacterial Infection
    Anti-inflammatory Role of Curcumin in LPS Treated A549 cells at Global Proteome level and on Mycobacterial infection. Suchita Singh1,+, Rakesh Arya2,3,+, Rhishikesh R Bargaje1, Mrinal Kumar Das2,4, Subia Akram2, Hossain Md. Faruquee2,5, Rajendra Kumar Behera3, Ranjan Kumar Nanda2,*, Anurag Agrawal1 1Center of Excellence for Translational Research in Asthma and Lung Disease, CSIR- Institute of Genomics and Integrative Biology, New Delhi, 110025, India. 2Translational Health Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, 110067, India. 3School of Life Sciences, Sambalpur University, Jyoti Vihar, Sambalpur, Orissa, 768019, India. 4Department of Respiratory Sciences, #211, Maurice Shock Building, University of Leicester, LE1 9HN 5Department of Biotechnology and Genetic Engineering, Islamic University, Kushtia- 7003, Bangladesh. +Contributed equally for this work. S-1 70 G1 S 60 G2/M 50 40 30 % of cells 20 10 0 CURI LPSI LPSCUR Figure S1: Effect of curcumin and/or LPS treatment on A549 cell viability A549 cells were treated with curcumin (10 µM) and/or LPS or 1 µg/ml for the indicated times and after fixation were stained with propidium iodide and Annexin V-FITC. The DNA contents were determined by flow cytometry to calculate percentage of cells present in each phase of the cell cycle (G1, S and G2/M) using Flowing analysis software. S-2 Figure S2: Total proteins identified in all the three experiments and their distribution betwee curcumin and/or LPS treated conditions. The proteins showing differential expressions (log2 fold change≥2) in these experiments were presented in the venn diagram and certain number of proteins are common in all three experiments.
    [Show full text]
  • Computational and Experimental Approaches for Evaluating the Genetic Basis of Mitochondrial Disorders
    Computational and Experimental Approaches For Evaluating the Genetic Basis of Mitochondrial Disorders The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Lieber, Daniel Solomon. 2013. Computational and Experimental Approaches For Evaluating the Genetic Basis of Mitochondrial Disorders. Doctoral dissertation, Harvard University. Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11158264 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Computational and Experimental Approaches For Evaluating the Genetic Basis of Mitochondrial Disorders A dissertation presented by Daniel Solomon Lieber to The Committee on Higher Degrees in Systems Biology in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the subject of Systems Biology Harvard University Cambridge, Massachusetts April 2013 © 2013 - Daniel Solomon Lieber All rights reserved. Dissertation Adviser: Professor Vamsi K. Mootha Daniel Solomon Lieber Computational and Experimental Approaches For Evaluating the Genetic Basis of Mitochondrial Disorders Abstract Mitochondria are responsible for some of the cell’s most fundamental biological pathways and metabolic processes, including aerobic ATP production by the mitochondrial respiratory chain. In humans, mitochondrial dysfunction can lead to severe disorders of energy metabolism, which are collectively referred to as mitochondrial disorders and affect approximately 1:5,000 individuals. These disorders are clinically heterogeneous and can affect multiple organ systems, often within a single individual. Symptoms can include myopathy, exercise intolerance, hearing loss, blindness, stroke, seizures, diabetes, and GI dysmotility.
    [Show full text]
  • 1. Ceramide: the Center of Sphingolipid Biosynthesis
    Introduction 1. Ceramide: the center of sphingolipid biosynthesis 1.1. Introducing the sphingolipid family The cell membrane contains three main classes of lipids: glycerolipids, sphingolipids and sterols (Futerman and Hannun 2004; Gulbins and Li 2006; Grassme et al. 2007). First discovered by J.L. W. Thudichum in 1876, sphingolipids were considered to play primarily structural roles in membrane formation (Zheng et al. 2006; Bartke and Hannun 2009). However, by the end of the twentieth century, sphingolipids were described as effector molecules which are involved in the regulation of apoptosis, cell proliferation, cell migration, senescence, and inflammation (Hannun 1996; Perry and Hannun 1998; Hannun and Obeid 2002; Futerman and Hannun 2004; Ogretmen and Hannun 2004; Reynolds et al. 2004; Fox et al. 2006; Modrak et al. 2006; Saddoughi et al. 2008). Sphingolipid metabolism pathways have a unique metabolic entry point, serine palmitoyl transferase (SPT) which forms 3-ketosphinganine, the first sphingolipid in the de novo pathway and a unique exit point, sphingosine-1-phosphate (S1P) lyase, which breaks down S1P into non-sphingolipid molecules. In this network, ceramide can be considered to be a metabolic hub because it occupies a central position in sphingolipid biosynthesis and catabolism (Hannun and Obeid 2008) (Figure 1). 1.2. Ceramide structure and metabolism Ceramide (Cer) from mammalian membranes is composed of sphingosine, which is an amide linked to a fatty acyl chain, varying in length from 14 to 26 carbon atoms (Mimeault 2002; Pettus et al. 2002; Ogretmen and Hannun 2004; Zheng et al. 2006) (Figure 1). Ceramide constitutes the metabolic and structural precursor for complex sphingolipids, which are composed of hydrophilic head groups, such as sphingomyelin, ceramide 1-phosphate, and glucosylceramide (Saddoughi et al.
    [Show full text]
  • Recombinant Human Tissue Transglutaminase for Diagnosis and Follow-Up of Childhood Coeliac Disease
    0031-3998/02/5106-0700 PEDIATRIC RESEARCH Vol. 51, No. 6, 2002 Copyright © 2002 International Pediatric Research Foundation, Inc. Printed in U.S.A. Recombinant Human Tissue Transglutaminase for Diagnosis and Follow-Up of Childhood Coeliac Disease TONY HANSSON, INGRID DAHLBOM, SIV ROGBERG, ANDERS DANNÆUS, PETER HÖPFL, HEIDI GUT, WOLFGANG KRAAZ, AND LARS KLARESKOG Department of Rheumatology, Karolinska Hospital, Stockholm, Sweden [T.H., S.R., L.K.]; Pharmacia Diagnostics, Uppsala, Sweden [I.D.]; Department of Pediatrics [A.D.] and Pathology [W.K.], Uppsala University Hospital, Uppsala, Sweden; and Pharmacia Diagnostics, Freiburg, Germany [P.H., H.G.] ABSTRACT Highly discriminatory markers for celiac disease are needed IgA and IgG anti-tTG. There was already an increase in IgA to identify children with early mucosal lesions and for rapid anti-tTG antibodies after 2 wk of gluten challenge (p Ͻ 0.01). follow-up. The aim of this study was to evaluate the potential of Although the criteria-based diagnosis of childhood celiac disease circulating anti-tissue transglutaminase (tTG) IgA and IgG anti- still depends on histologic evaluation of intestinal biopsies, bodies in the diagnosis and follow-up of childhood celiac dis- detection of anti-tTG antibodies provides useful complementary ease. An ELISA using recombinant human tTG was used to diagnostic information. The human recombinant tTG-based measure the levels of IgA and IgG anti-tTG antibodies in 226 ELISA can be used as a sensitive and specific test to support the serum samples from 57 children with biopsy-verified celiac diagnosis and may also be used in the follow-up of treatment in disease, 29 disease control subjects, and 24 healthy control childhood celiac disease.
    [Show full text]
  • Guinea Pig Transglutaminase Immunolinked Assay Does Not Predict Coeliac Disease in Patients with Chronic Liver Disease
    506 Gut 2001;49:506–511 Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with Gut: first published as 10.1136/gut.49.4.506 on 1 October 2001. Downloaded from chronic liver disease A Carroccio, L Giannitrapani, M Soresi, T Not, G Iacono, C Di Rosa, E Panfili, A Notarbartolo, G Montalto Abstract patients with atrophy of the intestinal Background—It has been suggested that mucosa were positive for anti-tTG while serological screening for coeliac disease all others were negative, including those (CD) should be performed in patients false positive in the ELISA based on with chronic unexplained hypertransami- guinea pig tTG as the antigen. nasaemia. Conclusions—In patients with elevated Aims—To evaluate the specificity for CD transaminases and chronic liver disease diagnosis of serum IgA antitissue trans- there was a high frequency of false glutaminase (tTG) determination in con- positive anti-tTG results using the ELISA secutive patients with chronic based on tTG from guinea pig as the anti- hypertransaminasaemia using the most gen. Indeed, the presence of anti-tTG did widely utilised ELISA based on tTG from not correlate with the presence of EmA or guinea pig as the antigen. CD. These false positives depend on the Patients and methods—We studied 98 presence of hepatic proteins in the com- patients with chronic hypertransamina- mercial tTG obtained from guinea pig saemia, evaluated for the first time in a liver and disappear when human tTG is hepatology clinic. Serum anti-tTG and used as the antigen in the ELISA system. antiendomysial (EmA) assays were per- We suggest that the commonly used tTG formed.
    [Show full text]
  • El Maestro De La Medicina Platense Christofredo Jakob, Discípulo Y Amigo De Adolf Von Strümpell
    ISSN: 0328-0446 Electroneurobiología vol. 14 (1), pp. 115-170, 2006 El Maestro de la medicina platense Christofredo Jakob, discípulo y amigo de Adolf von Strümpell por Vicente Oddo Médico, poeta e historiador santiagueño, publicó en los Anuarios de El Liberal "Los médicos y la medicina en Santiago del Estero desde la fundación", en 1968; y "Panorama de la ciencia en Santiago del Estero desde mediados del S. XVI hasta comienzos del S. XX" en 1973. Al presente lleva publicados trece libros, desde uno filosófico, Medicina y Eudemonismo, Sgo. del Estero, 1972, hasta otro de historia médica provincial, Historia de la Medicina en Santiago del Estero - Su evolución conjunta al desarrollo científico-técnico cultural local, desde mediados del siglo XVI hasta promediar el siglo XX, Sgo. del Estero, 1999, 465 pp; y en colaboración con el lingüista Domingo A. Bravo, Estudio semántico del léxico médico de la Lengua Quichua Santiagueña: Buenos Aires, Academia Argentina de Letras, 1992. Es Académico Nacional Co- rrespondiente de la Academia Nacional de Medicina de Buenos Aires (desde 1982), de la Aca- demia de Ciencias Médicas de Córdoba (desde 1975) y de la Academia Argentina de la Historia (desde 1987). Recibió en 2005 el Premio Diego Alcorta de la Asociación Médica Argentina. Contacto / correspondence: voddo[at-]arnet.com.ar y Mariela Szirko Contacto / correspondence: Postmaster[at--]neurobiol.cyt.edu.ar Electroneurobiología 2006; 14 (1), pp. 115-170; URL <http://electroneubio.secyt.gov.ar/index2.htm> Copyright ©2006 Electroneurobiología. Este es un artículo de acceso público; la copia exacta y redistribución por cualquier medio están permitidas bajo la condición de conservar esta noticia y la referencia completa a su publicación actual incluyendo la URL original (ver arriba).
    [Show full text]
  • Neuroscience in Nazi Europe Part II: Resistance Against the Third Reich Lawrence A
    HISTORICAL REVIEW Neuroscience in Nazi Europe Part II: Resistance against the Third Reich Lawrence A. Zeidman ABSTRACT: Previously, I mentioned that not all neuroscientists collaborated with the Nazis, who from 1933 to 1945 tried to eliminate neurologic and psychiatric disease from the gene pool. Oskar and Cécile Vogt openly resisted and courageous ly protested against the Nazi regime and its policies, and have been discussed previously in the neurology literature. Here I discuss Alexander Mitscherlich, Haakon Saethre, Walther Spielmeyer, Jules Tinel, and Johannes Pompe. Other neuroscientists had ambivalent roles, including Hans Creutzfeldt, who has been discussed previously. Here, I discuss Max Nonne, Karl Bonhoeffer, and Oswald Bumke. The neuroscientists who resisted had different backgrounds and moti vations that likely influenced their behavior, but this group undoubtedly saved lives of colleagues, friends, and patients, or at least prevented forced sterilizations. By recognizing and understanding the actions of these heroes of neuroscience, we pay homage and realize how ethics and morals do not need to be compromised even in dark times. RÉSUMÉ: Neuroscience en Europe sous domination nazie, 2e partie : résistance contre le Troisième Reich. J’ai mentionné antéri eurement que tous les neuroscientifiques n’avaient pas collaboré avec les nazis qui, de 1933 à 1945, ont tenté d’éliminer la maladie neurologique et psychiatrique du patrimoine génétique. Oskar et Cécile Vogt se sont opposés ouvertement et ont protesté courageusement contre le régime nazi et ses politiques. Ce sujet a déjà été exposé dans la littérature neurologique. Je discute ici d’Alexander Mitscherlich, de Haakon Saethre, de Walther Spielmeyer, de Jules Tinel et de Johannes Pompe.
    [Show full text]
  • Past ABPN Giants in Neurology
    ABPN 75th Anniversary Celebration Giants of Neurology Mark L Dyken, MD Professor Emeritus of Neurology Indiana University Medical School September 26, 2009 ABPN “NEUROLOGY GIANTS” (American Neurological Association & American Academy of Neurology” ANA Presidents 1. Lewis J. Pollock 1942 2. Edwin G. Zabriskie 1944 3. Henry W. Woltman 1950 4. Hans H. Reese 1953 5. Roland P . Mackay 1954 6. Percival Bailey 1955 7. Johannes M. Nielsen 1956 8. H. Houston Merritt 1957 AAN Presidents 9. Bernard J. Alpers 1959 1. Abe B. Baker* 1948-1951 10.RllDJRussell DeJong 1965 2. FiMFtFrancis M. Forster 1957-1959 11.Adolph L. Sahs 1968 3. Augustus S. Rose* 1959-1961 12.Augustus S. Rose 1969 4. Adolph L. Sahs* 1961-1963 13.Melvin D. Yahr 1970 5. Sidney Carter 1969-1971 14.Abe B. Baker 1971 *Also ANA ANA Vice Presidents 1. Louis Casamajor 1939 2. Frederich P. Moersch 1952 3. Alphonse Vonderahe 1955 4. Paul I. Yakovlev 1959 5. Charles Rupp 1960 6. Knox Finley 1963 7. Alexander T. Ross 1967 •M.D. 1906 College of Physicians and Surgeons •1909 -1948 New York Neurological Institute . Assistant Attending to Professor Emeritus. •Early interest in Child Neurology followed Bernard Sachs and was followed by Sidney Carter and then Darryl DeVivo •President of several psychiatric societies, but defensive about N before P in ABPN, •“Neurologists, you know, have much more reverence for the alphabet than psychiatrists have.” •"Personally I don't give a damn …” One of most colorful and the most controversial of all ABPN directors. ((yThe Lobotomist: by Jack El-Hai , Last Resort: Psychosurgery and Limits of Medicine by Pressman JD.
    [Show full text]
  • Sanger Brown and Edward Schäfer Before Heinrich Klüver and Paul Bucy: Their Observations on Bilateral Temporal Lobe Ablations
    NEUROSURGICAL FOCUS Neurosurg Focus 43 (3):E2, 2017 Sanger Brown and Edward Schäfer before Heinrich Klüver and Paul Bucy: their observations on bilateral temporal lobe ablations Prasad S. S. V. Vannemreddy, MD,1 and James L. Stone, MD2 1Department of Neurosurgery, University of Illinois at Chicago, Illinois; and 2Department of Neurosurgery, NYU Langone Medical Center, New York, New York Fifty years before a report on the complete bitemporal lobectomy syndrome in primates, known as the Klüver-Bucy syndrome, was published, 2 talented investigators working at the University College in London, England—neurologist Sanger Brown and physiologist Edward Schäfer—also made this discovery. The title of their work was “An investigation into the functions of the occipital and temporal lobes of the monkey’s brain,” and it involved excisional brain surgery in 12 monkeys. They were particularly interested in the then-disputed primary cortical locations relating to vision and hearing. However, following extensive bilateral temporal lobe excisions in 2 monkeys, they noted peculiar behavior including ap- parent loss of memory and intelligence resembling “idiocy.” These investigators recognized most of the behavioral find- ings that later came to be known as the Klüver-Bucy syndrome. However, they were working within the late-19th-century framework of cerebral cortical localizations of basic motor and sensory functions. Details of the Brown and Schäfer study and a glimpse of the neurological thinking of that period is presented. In the decades following the pivotal work of Klüver and Bucy in the late 1930s, in which they used a more advanced neuro- surgical technique, tools of behavioral observations, and analysis of brain sections after euthanasia, investigators have elaborated the full components of the clinical syndrome and the extent of their resections.
    [Show full text]